CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED
Get an alert when CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-10-10 (in 5mo)
Last made up 2025-09-26
Watchouts
Cash
£190K
Latest balance sheet
Net assets
£528K
Equity attributable
Employees
11
Average over period
Profit before tax
-£2M
Period ending 2024-12-31
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
In view of the above, the directors have concluded that a material uncertainty exists that may cast significant doubt upon the group's ability to continue as a going concern. Nevertheless, after making enquiries, and considering the uncertainties described above, the directors have concluded that it is appropriate to continue to adopt the going concern basis in preparing the financial statements.
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £108,300 | — | |
| Operating profit | -£3,446,700 | -£3,066,000 | |
| Profit before tax | -£3,684,600 | -£2,345,000 | |
| Net profit | -£3,690,700 | -£2,347,000 | |
| Cash | £290,300 | £189,800 | |
| Total assets less current liabilities | £4,610,100 | £4,646,600 | |
| Net assets | -£153,200 | £528,000 | |
| Equity | -£153,200 | £528,000 | |
| Average employees | 12 | 11 | |
| Wages | £1,419,300 | £1,373,600 | |
| Directors' remuneration | £514,300 | £508,100 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | -74.8% | -66.0% | |
| Gearing (liabilities / total assets) | 102.8% | 90.4% | |
| Current ratio | 0.70x | 0.65x | |
| Interest cover | -14.49x | — |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED 2014-11-26 → present
- CLINETIK LIMITED 2014-09-26 → 2014-11-26
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Frazier & Deeter (UK Audit) LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“In view of the above, the directors have concluded that a material uncertainty exists that may cast significant doubt upon the group's ability to continue as a going concern. Nevertheless, after making enquiries, and considering the uncertainties described above, the directors have concluded that it is appropriate to continue to adopt the going concern basis in preparing the financial statements.”
Group structure
- CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED · parent
- Cambridge Medical Technologies, LLC 100%
- Clinitech, LLC 100%
- CMT Japan Inc 100%
- Clinitech Holdings Limited 100%
- Clinitech Limited 100%
Significant events
- “Since the end of the year, the company has received £2.3 million in new investment financing.”
- “On 22 August 2025 the Company received confirmation that its two non-trading subsidiaries, Clinitech Holdings Limited and Clinitech Limited, were in the process of being struck off.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| COOKE, James | Director | 2016-05-23 | Jan 1966 | British |
| JACHMANN, Emil | Director | 2014-09-26 | Mar 1947 | American |
| LACEY-SOLYMAR, Michael Julian | Director | 2015-10-16 | Feb 1963 | British |
| PRESS, Richard | Director | 2025-09-17 | Jan 1939 | American |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CORNELIUS, James | Director | 2017-02-02 | 2025-11-11 |
| DIBDEN, Lindsay George | Director | 2017-02-02 | 2019-02-13 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Emil Frederick Jachmann | Individual | Shares 25–50% | 2016-04-06 | Active |
Filing timeline
Last 20 of 101 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-23 | SH01 | capital | Capital allotment shares | |
| 2026-03-23 | SH01 | capital | Capital allotment shares | |
| 2026-03-23 | SH01 | capital | Capital allotment shares | |
| 2025-11-23 | SH01 | capital | Capital allotment shares | |
| 2025-11-14 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-22 | SH01 | capital | Capital allotment shares | |
| 2025-10-21 | SH01 | capital | Capital allotment shares | |
| 2025-09-26 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-09-26 | AA | accounts | Accounts with accounts type group | |
| 2025-09-25 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-06 | SH01 | capital | Capital allotment shares | |
| 2025-09-06 | SH01 | capital | Capital allotment shares | |
| 2025-08-03 | SH01 | capital | Capital allotment shares | |
| 2025-08-03 | SH01 | capital | Capital allotment shares | |
| 2025-05-27 | SH01 | capital | Capital allotment shares | |
| 2024-11-21 | SH01 | capital | Capital allotment shares | |
| 2024-10-07 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-01 | AA | accounts | Accounts with accounts type group | |
| 2024-08-06 | SH01 | capital | Capital allotment shares | |
| 2024-06-26 | SH01 | capital | Capital allotment shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 15
- Capital events
- 14
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.